Graham Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.9K | Sell |
12,052
-154,191
| -93% | -$1.06M | ﹤0.01% | 1182 |
|
|
2025
Q1 | $479K | Buy |
166,243
+21,301
| +15% | +$61.3K | 0.01% | 802 |
|
|
2024
Q4 | $681K | Buy |
144,942
+53,726
| +59% | +$253K | 0.01% | 593 |
|
|
2024
Q3 | $326K | Buy |
+91,216
| New | +$326K | 0.01% | 722 |
|
|
2023
Q4 | – | Sell |
-11,845
| Closed | -$52.6K | – | 1088 |
|
|
2023
Q3 | $52.6K | Sell |
11,845
-20,103
| -63% | -$89.3K | ﹤0.01% | 949 |
|
|
2023
Q2 | $105K | Sell |
31,948
-115,031
| -78% | -$380K | ﹤0.01% | 873 |
|
|
2023
Q1 | $419K | Buy |
146,979
+125,626
| +588% | +$358K | 0.01% | 782 |
|
|
2022
Q4 | $155K | Buy |
+21,353
| New | +$155K | ﹤0.01% | 973 |
|